Advent International to Acquire PatientPoint in Healthcare Deal - InforCapital

Boston and Cincinnati, August 25, 2025 – Advent International, a leading global private equity firm, has signed a definitive agreement to acquire PatientPoint, the largest digital point-of-care engagement network in the United States. PatientPoint delivers behavior-changing content to patients and providers through a vast, interconnected platform spanning 30,000 physician offices and reaching 125,000 healthcare providers nationwide.

PatientPoint has over 35 years of experience enhancing the healthcare experience by delivering targeted, educational content at critical moments of care. Its platform drives patient behavior change, health literacy, and provides a powerful channel for pharmaceutical brands, advocacy groups, and healthcare marketers to engage with highly segmented audiences.

Advent’s investment is expected to accelerate PatientPoint’s growth by supporting network expansion, product innovation, and deeper engagement with healthcare sponsors. The acquisition aligns with Advent’s focus on healthcare and tech-enabled services, following other investments in companies like Iodine, Simtra BioPharma Solutions, Mediq, and Apollo HealthCo.

PatientPoint’s existing leadership, including CEO Sean Slovenski, will remain in place and continue executing the company’s mission of delivering measurable health outcomes through trusted digital content and tools. With Advent’s operational support and healthcare expertise, the company plans to scale delivery of personalized treatment messaging, advanced analytics, and cross-platform integrations to healthcare partners across the U.S.

This deal follows a wave of private equity interest in digital health infrastructure, especially platforms that connect healthcare providers, patients, and sponsors at the point of care. In early 2025, General Atlantic invested in Phreesia, a patient intake and engagement software provider. Warburg Pincus recently expanded its stake in Zocdoc, while TPG led a funding round in HealthVerity to build scalable healthcare data networks. These investments reflect ongoing momentum toward digital-first care coordination and outcomes-based marketing.

PatientPoint’s network is uniquely positioned to benefit from this transformation, offering real-time, location-based access to patients during the moments that most influence decision-making. It also enables pharma and health brands to deploy more measurable, targeted campaigns as regulatory and ROI pressures reshape healthcare communications strategies.

Jefferies and Citi served as financial advisors to PatientPoint, with Gibson Dunn & Crutcher providing legal counsel. Solomon Partners and Ropes & Gray advised Advent. The transaction is expected to close in Q4 2025, pending regulatory approvals and customary closing conditions.

PatientPoint will continue operating under its existing brand and leadership, supported by Advent’s global network of advisors, resources, and deep healthcare domain expertise.